Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

"Mitolyn is more than just a supplement,” says Peter Newman, Co-Founder of Mitolyn. "It's a natural way for people to reclaim control over their health, energy, and metabolism, addressing the root ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.